Is entecavir monotherapy effective in suppressing hepatitis B virus after liver transplantation?
Although only 26% of patients had complete viral suppression at the time of transplant, 91% lost HBsAg, with 98.8% achieving undetectable levels of HBV DNA. A hepatitis B immunoglobulin-free regimen of entecavir monotherapy is effective after liver transplantation for chronic hepatitis B.
MPD involvement in PNETs may serve as an imaging sign indicating an aggressive clinical course.